The active pharmaceutical ingredient is Linezolid
Colorless to light brown, clear liquid.
【Name】 | Common Name:Linezolid Dextrose Injection |
---|---|
【Ingredient】 | The active pharmaceutical ingredient is Linezolid |
【Description】 | Colorless to light brown, clear liquid. |
【Indications】 | This product is used to treat the following infections caused by the specific microbial susceptible strains: Vancomycin-resistant Enterococcus faecium infections, Nosocomial pneumonia, Complicated skin and skin soft tissue infections, Uncomplicated skin and skin soft tissue infections , Community-acquired pneumonia and concomitant bacteremia. |
【Strength】 | (1)100ml:0.2 g linezolid, 4.6 g anhydrous dextrose (2)300ml:0.6 g linezolid, 13.8 g anhydrous dextrose |
【Dosage and Administration】 | The recommended dosage administration of this product for treatment of infections is described in the instructions. |
2015: First-to-market generic drug in China
Included in NRDL since its launch